Stability study of pharmacy compounded high-dose ambroxol hydrochloride capsules for an n-of-1 clinical trial involving Dutch patients with Gaucher disease type 3
The 75 mg ambroxol HCl capsules are stable for at least 6 months at room temperature. This paper provides guidance to pharmacies for compounding of high-dose ambroxol HCl capsules to ensure the availability of ambroxol for patients in need.
Authors
- Abraham Wilhelm
- Natalja Bouwhuis (ORCID: https://orcid.org/0000-0003-2268-7555)
- Yuma A. Bijleveld
- Erik Swart
- C E M Hollak
- Anne-Loes E Gerards
- Hoang Lan Le
Institutions
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1136/ejhpharm-2025-004729
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medical Research Council